FindTrial
Sign In

Change in level of blood immunity before and after general anaesthesia in patients with breast cancer

Immunomodulatory effects of balanced general anaesthesia in patients with breast cancer-an observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/081942
Enrollment
20
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA2 patients 2.scheduled for breast cancer surgeries under general anaesthesia

Exclusion criteria

Exclusion criteria: Patients with 1. endocrine disease 2. immunological disease 3. chronic liver disease

Design outcomes

Primary

MeasureTime frame
To assess the change in proinflammatory mediator IL-6 before and after general anaesthesiaTimepoint: Before and 2 hours after anesthesia—

Secondary

MeasureTime frame
To assess the change in serum levels of TNF, IL1, IL10, IFN, IL2, leukocytes,lymphocytes, neutrophils, monocytes, eosinophils and basophils caused by induction of general anaesthesiaTimepoint: Before and 2 hours after anaesthesia—

Countries

India

Contacts

Public ContactNitu PV

Amrita Institute of medical Sciences

nituveesundeep@gmail.com9495962020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026